Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Cirrhosis
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Cirrhosis
    Liver Transplant Outcomes Similar for Patients With Nonalcoholic vs Alcoholic Cirrhosis - (DGNews)
    TopAbstracts in Cirrhosis 11/17/2009 - (DGNews)
    Satavaptan Shows Poor Survival, Despite Modest Effectiveness in the Management of Recurrent Ascites: Presented at AASLD - (DGDispatch)
    Viral Load Predicts Outcome of Liver Transplant Recipients With Hepatitis C: Presented at AASLD - (DGDispatch)
    Rifaximin Protects Patients With Cirrhosis From Breakthrough Hepatic Encephalopathy Over Long Term: Presented at AASLD - (DGDispatch)

    News archive

     Recent webcasts/CME - Cirrhosis

    Webcasts/CME archive

     Recent cases - Cirrhosis
      Incisional Hernia as an Unusual Cause of Hepatic Encephalopathy in a 62-Year-Old Man with Cirrhosis: A Case Report
      Gefitinib for Non-Small Cell Lung Cancer Patients with Liver Cirrhosis
      Intra-Hepatic Splenosis as an Unexpected Cause of a Focal Liver Lesion in a Patient with Hepatitis C and Liver Cirrhosis: A Case Report
      Black Esophagus
      A Case of Non-O1 and Non-O139 Vibrio cholerae Septicemia with Endophthalmitis in a Cirrhotic Patient

      Cases archive
        




      my personal edition > cirrhosis > news
      divider

        E-Mail this DGDispatch to a colleague

      DGDispatch


      Branched-Chain Amino Acid Supplementation May Help Prevent Infection in Cirrhotic Patients: Presented at AASLD

      By Maria Bishop

      BOSTON, MA -- November 5, 2004 -- Oral supplementation with branched-chain amino acids (BCAA) may reduce the risk of lethal bacterial infections in patients with decompensated liver cirrhosis, according to a small-cohort study reported here on November 1st at the 55th Annual Meeting of the American Society for Liver Diseases.

      Previous research found that phagocytic function of neutrophils is impaired in cirrhotic patients. In this study, a team of researchers from Japan found that BCAA supplementation improved phagocytic function of neutrophils, preventing bacteremia and spontaneous bacterial peritonitis from developing in patients with cirrhosis -- especially those with decompensated cirrhosis.

      In the study, five women with decompensated cirrhosis were treated with 12 g daily of BCAA for 3 months. The women had a median age of 60 years.

      Lead researcher Ikuo Nakamura, MD, PhD, Attending Associate, Division of Gastroenterology & Hepatology, Omiya Medical Center, Jichi Medical School, Saitama, evaluated phagocytic function and bactericidal activity of neutrophils in peripheral blood as well as Fisher's ratios at baseline and at 1 and 3 months of BCAA supplementation.

      Neutrophil phagocytic function improved in 3 of 5 patients at 1 month, and in all patients at 3 months. The changes from baseline were significant at 3 months (P <.05). Fisher's ratios were also significantly increased at 3 months compared with baseline (P <.01).

      Although the changes were not statistically different, bactericidal activity was improved in 3 of 5 patients at 3 months. Similarly, serum albumin levels were non-significantly increased at 1 and 3 months in 3 of 5 patients.

      The mechanisms of improvement in phagocytic activity in neutrophils as a result of BCAA have yet to be elucidated, Dr. Nakamura noted, adding that further studies should help increase the knowledge base on this subject.


      [Presentation title: "Restoration of Phagocytic Function of Neutrophils of Patients With Decompensated Liver Cirrhosis by Oral Supplementation of Branched-Chain Amino Acids." Abstract 808]



      E-Mail this DGDispatch to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send